CL vs MGRX · P/E 34, rev $10.69B vs rev $456.0K
Colgate-Palmolive Company (CL) versus Mangoceuticals, Inc. Common Stock (MGRX) — a side-by-side from cached financials, not a winner call.
Colgate-Palmolive Company (CL) is a household & personal products company listed on US.
Mangoceuticals, Inc. Common Stock (MGRX) is a health information services company listed on US.
Latest reported CL revenue for 2026-06-30 was $10.69B. Net income was $1.34B. CL currently screens at market cap $70.88B and trailing P/E 34.3.
Latest reported MGRX revenue for 2025-12-31 was $456.0K. Net income was -$20.6M. Revenue was down 26.0% from 2024-12-31 to 2025-12-31. MGRX currently screens at market cap $16.3M.
CL currently screens at market cap $70.88B and trailing P/E 34.3. MGRX currently screens at market cap $16.3M.
Not investment advice. Open the CL and MGRX stock pages for the full models.
Not investment advice.